PHLPP2 as a novel metastatic and prognostic biomarker in non-small cell lung cancer patients.

Hongmei WangRuixue GuFanglin TianYuechao LiuWeina FanGuiqin XueLi CaiYing Xing

Published in: Thoracic cancer (2019)

Taken together, our findings show that PHLPP2 is a robust clinical marker for NSCLC survival and could serve as a potential therapeutic target.

Keyphrases